Scpharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $16,041 | $11,752 | $12,150 | $10,026 |
Gross Profit | 11,030 | 8,281 | 8,185 | 6,715 |
EBITDA | -14,294 | -17,757 | -17,299 | -33,250 |
EBIT | -14,358 | -17,820 | -17,283 | -33,163 |
Net Income | -18,024 | -19,742 | -18,845 | -35,105 |
Net Change In Cash | 16,041 | 11,752 | 12,150 | 10,026 |
Free Cash Flow | -16,111 | -17,139 | -15,198 | -17,433 |
Cash | 40,809 | 57,544 | 75,655 | 91,484 |
Basic Shares | 53,719 | 53,676 | 44,519 | 46,558 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $36,332 | $13,593 | $2,063 | $0 |
Gross Profit | 24,971 | 9,782 | -468 | -438 |
EBITDA | -77,430 | -46,061 | -33,068 | -25,021 |
EBIT | -77,578 | -46,687 | -33,536 | -25,459 |
Net Income | -85,148 | -54,810 | -36,838 | -28,034 |
Net Change In Cash | 36,332 | 13,593 | 2,063 | 0 |
Cost of Revenue | -3,207 | 2,449 | ||
Free Cash Flow | -70,559 | -59,284 | -34,598 | -27,160 |
Cash | 75,655 | 46,814 | 71,061 | 74,268 |
Basic Shares | 44,519 | 38,513 | 28,358 | 27,351 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.34 |
2025-03-31 | -$0.37 |
2024-12-31 | -$0.31 |
